Cargando…
Risk of Congenital Heart Disease in Newborns with Prenatal Exposure to Anti-depressant Medications
Introduction It is uncertain whether the use of selective serotonin-reuptake inhibitors (SSRI) and other anti-depressants during pregnancy is associated with an increased risk of congenital heart disease (CHD) in newborn. There have been various studies showing a number of adverse outcomes, includin...
Autores principales: | Desai, Pooja H, Yagnik, Priyank J, Ross Ascuitto, Nancy, Prajapati, Parna, Sernich, Steffan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634285/ https://www.ncbi.nlm.nih.gov/pubmed/31328065 http://dx.doi.org/10.7759/cureus.4673 |
Ejemplares similares
-
The Association Between Maternal Age and the Prevalence of Congenital Heart Disease in Newborns from 2016 to 2018 in Single Cardiac Center in Jeddah, Saudi Arabia
por: Hashim, Sara T, et al.
Publicado: (2020) -
Preeclampsia and Fetal Congenital Heart Defects
por: Ferreira, Bárbara D., et al.
Publicado: (2022) -
Epidemiology, Genetics and Epigenetics of Congenital Heart Diseases in Twins
por: Balasubramanian, Ramya, et al.
Publicado: (2021) -
Congenital Heart Disease and Its Association in Children With Down Syndrome
por: Rehman, Yasir, et al.
Publicado: (2022) -
The Impact of Prenatal Diagnosis in the Evolution of Newborns with Congenital Heart Disease
por: Toma, Daniela, et al.
Publicado: (2023)